A Double‐Blind, Randomized, Controlled Trial of Topical Polysporin Triple Compound Versus Topical Mupirocin for the Eradication of Colonization with Methicillin‐Resistant Staphylococcus aureus in a Complex Continuing Care Population
Author(s) -
Sharon O'Grady,
Zahir Hirji,
B Pejcic-Karapetrovic,
Scott Fung,
Helen Dedier,
J Takata-Shewchuk,
Kunyan Zhang,
John Conly
Publication year - 2009
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2009/274896
Subject(s) - mupirocin , medicine , colonization , staphylococcus aureus , methicillin resistant staphylococcus aureus , population , microbiology and biotechnology , biology , bacteria , environmental health , genetics
Intranasal mupirocin or Polysporin Triple (PT) ointment (polymyxin B, bacitracin, gramicidin), in combination with chlorhexidine body washes, have been used for eradicating methicillin-resistant Staphylococcus aureus (MRSA), but no comparative studies have been done.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom